XML 52 R34.htm IDEA: XBRL DOCUMENT v3.25.1

Summary of Significant Accounting Policies (Tables)

8 Months Ended

Dec. 31, 2024

Accounting Policies [Abstract]

Schedules of Concentration of Credit Risk

 Schedules of Concentration of Credit Risk

		December 31,				April 30,
		2024				2024				2023
Customer A			36	%			-*				-*
Customer B			17	%			-*				-*
Customer C			15	%			-*				-*
Customer D			-*				53	%			20	%
Customer E			-*				24	%			-*
Customer F			-*				-*				24	%
Customer G			-*				-*				14	%
Customer H			-*				-*				10	%

* Accounts Receivable was less than 10%

Schedules of Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation

The Company calculated the estimated fair value of the convertible notes payable for the eight months ended December 31, 2024 using the following assumptions:

 Schedules of Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation

Issuance date			10/1/2024 - 11/26/2024
Maturity date			10/1/2026 - 11/26/2026
Stock price			3.06 – 11.03
Expected volatility factor			92.8 – 103.2	%
Risk-free interest rate			4.21 - 5.21	%

Schedules of Changes in Convertible Notes Payable Measured at Fair Value

The following table presents changes in the Level 3 convertible notes payable measured at fair value for the eight months ended December 31, 2024:

 Schedules of Changes in Convertible Notes Payable Measured at Fair Value

Balance, May 1, 2024		$	—
Additions			13,456,000
Fair value measurement adjustments			13,120,940
Conversion into common stock			(26,576,940	)
Balance, December 31, 2024		$	—

Schedules of Revenue Disaggregated by Revenue Type

The following table presents the Company’s revenue disaggregated by revenue type:

 Schedules of Revenue Disaggregated by Revenue Type

		December 31, 2024				2024				2023
		For the Eight Months Ended				For the Year Ended April 30,
		December 31, 2024				2024				2023
Contract related		$	886,440			$	4,173,005			$	1,312,427
Product related			3,963,864				13,663,377				3,308,407
Total		$	4,850,304			$	17,836,382			$	4,620,834

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

 Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

		December 31, 2024				April 30, 2024				April 30, 2023
Series B Preferred Stock, as converted			3,896				3,896				822,230
Stock options			5,242,308				6,779,934				4,784,809
Warrants			914,056				2,275,999				1,539,999
Restricted stock			1,544,027				175,130				781,060
Total			7,704,287				9,234,959				7,928,098

X

- Definition

Tabular disclosure of revenue recognition disaggregated revenue.

+ References

No definition available.

+ Details

Name:	RCAT_RevenueRecognitionDisaggregatedRevenueByTypeTableTextBlock
Namespace Prefix:	RCAT_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_AccountingPoliciesAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

+ Details

Name:	us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 820
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/820/tableOfContent

+ Details

Name:	us-gaap_FairValueMeasurementInputsDisclosureTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482662/260-10-50-1

+ Details

Name:	us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 21
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482907/825-10-50-21

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 20
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482907/825-10-50-20

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 18
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-18

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 20
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-20

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 16
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-16

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 21
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-21

+ Details

Name:	us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration